Analysis for the major contributor of collagenase to the primary cleavage of type II collagens in cartilage degradation

Modern Rheumatology

Volumn 15, Issue 3, 2005, Pages 180-186

  Yoshida, Mamoru ^a   Tsuji, Michiko ^a   Funasaki, Hiroki ^a   Kan, Iwao ^a   Fujii, Katsuyuki ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cartilage degradation; Collagenase; RNA interference; Type II collagen

Indexed keywords

COLLAGEN TYPE 2; COLLAGENASE; INTERLEUKIN 1; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REPRESSION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; OSTEOARTHRITIS; PH; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN TARGETING; RHEUMATOID ARTHRITIS;

EID: 22144489202     PISSN: 14397595     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10165-005-0384-z     Document Type: Article

References (23)

1. Hollander AP, Heathfield TF, Webber C, Iwata Y, Bourne R, Rorabeck C, et al. Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest 1994;93:1722-32.
2. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997;99: 1534-45.
3. Freemont AJ, Byers RJ, Taiwo YO, Hoyland JA. In situ zymographic localization of type II collagen degrading activity in osteoarthritic human articular cartilage. Ann Rheum Dis 1999;58: 357-65.
4. Poole AR. Cartilage in health and disease in Arthritis and allied conditions. In: Koopman WJ, editor. Textbook of rheumatology. 14th ed. Philadelphia: Lippincott Williams and Wilkins; 2000. p. 2226-84.
5. Kojima T, Mwale F, Yasuda T, Girard C, Poole AR, Laverty S. Early degradation of type IX and type II collagen with the onset of experimental inflammatory arthritis. Arthritis Rheum 2001;44: 120-7.
6. Mort JS, Dodge GR, Roughley PJ, Liu J, Finch SF, DiPasquale G, et al. Direct evidence for active metalloproteinases mediating matrix degradation in interleukin-1 stimulated articular cartilage. Matrix 1993;13:95-102.
7. Kozaci LD, Buttle DJ, Hollander AP. Degradation of type II collagen, but not proteoglycan, correlates with metalloproteinase activity in cartilage explant cultures. Arthritis Rheum 1997;40:164-74.
8. Shlopov BV, Lie W-R, Mainardi CL, Cole AA, Chubinskaya S, Hasty KA. Osteoarthritic lesions: Involvement of three different collagenases. Arthritis Rheum 1997;40:2065-74.
9. Freemont AJ, Hampson V, Tilman R, Goupille P, Taiwo YO, Hoyland JA. Gene expression of matrix metalloproteinase 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific. Ann Rheum Dis 1997;56:542-9.
10. Tetlow LC, Woolley DE. Comparative immunolocalization studies of collagenase 1 and collagenase 3 production in the rheumatoid lesion, and by human chondrocytes and synoviocytes in vitro. Br J Rheumatol 1998;37:64-70.
11. Fernandes JC, Martel-Pelletier J, Lascau-Coman V, Moldovan F, Jovanovic D, Raynaud JP, et al. Collagenase-1 and collagenase-3 synthesis in normal and early experimental osteoarthritic canine cartilage: An immunohistochemical study. J Rheumatol 1998;25: 1585-94.
12. Huebner JL, Otterness IG, Freund EM, Caterson B, Kraus VB. Collagenase 1 and collagenase 3 expression in a guinea pig model of osteoarthritis. Arthritis Rheum 1998;41:877-90.
13. Tetlow LC, Adlam DJ, Woolley DE. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: Associations with degenerative changes. Arthritis Rheum 2001;44:585-94.
14. Cole AA, Chubinskaya S, Schumacher B, Huch K, Cs-Szabo G, Yao J, et al. Chondrocyte matrix metalloproteinase-8: Human articular chondrocytes express neutrophil collagenase. J Biol Chem 1996;271:11023-6.
15. Borden P, Solymar D, Sucharczuk A, Lindman B, Cannon P, Heller R. Cytokine control of interstitial collagenase and collagenase-3 gene expression in human chondrocytes. J Biol Chem 1996; 271:23577-81.
16. Chubinskaya S, Huch K, Mikecz K, Szabo C, Hasty K, Kuettner K, et al. Chondrocyte matrix metalloproteinase-8: Up-regulation of neutrophil collagenase by interleukin-1β in human cartilage from knee and ankle joints. Lab Invest 1996;74:232-40.
17. Tardif G, Pelletier J-P, Dupuis M, Geng C, Cloutier J-M, Martel-Pelletier J. Collagenase 3 production by human osteoarthritic chondrocytes in response to growth factors and cytokines is a function of the physiological state of the cells. Arthritis Rheum 1999;42:1147-58.
18. Mengshol JA, Vincenti MP, Coon CI, Barchowsky A, Brinckerhoff CE. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-JUN N-terminal kinase, and nuclear factor κB. Arthritis Rheum 2000; 43:801-11.
19. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411:494-8.
20. Aydelotte MB, Kuettner KE. Differences between sub-populations of cultured bovine articular chondrocytes. I. Morphology and cartilage matrix production. Connect Tissue Res 1988;18:205-22.
21. Knäuper V, López-Otin C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem 1996;271:1544-50.
22. Kafienah W, Bromme D, Buttle DJ, Croucher LJ, Hollander AP. Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem J 1998;331:727-32.
23. Lang A, Horler D, Baici A. The relative importance of cysteine peptidases in osteoarthritis. J Rheumatol 2000;27:1970-9.